{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT01322789",
      "OrgStudyIdInfo": {
        "OrgStudyId": "HCFMRPUSP 2"
      },
      "SecondaryIdInfoList": {
        "SecondaryIdInfo": [
          {
            "SecondaryId": "CNPQ 552266/2005-1",
            "SecondaryIdType": "Other Grant/Funding Number",
            "SecondaryIdDomain": "CNPQ 552266/2005-1"
          }
        ]
      },
      "Organization": {
        "OrgFullName": "University of Sao Paulo",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Safety and Efficacy of Mesenchymal Stem Cells in Newly-diagnosed Type 1 Diabetic Patients",
      "OfficialTitle": "Safety and Efficacy of Mesenchymal Stem Cells in Newly-diagnosed Type 1 Diabetic Patients"
    },
    "StatusModule": {
      "StatusVerifiedDate": "November 2010",
      "OverallStatus": "Unknown status",
      "LastKnownStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "September 2008"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "November 2015",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "December 2015",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "December 7, 2010",
      "StudyFirstSubmitQCDate": "March 24, 2011",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "March 25, 2011",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "March 24, 2011",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "March 25, 2011",
        "LastUpdatePostDateType": "Estimate"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyOldNameTitle": "Júlio Cesar Voltarelli",
        "ResponsiblePartyOldOrganization": "Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo"
      },
      "LeadSponsor": {
        "LeadSponsorName": "University of Sao Paulo",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "Type 1 diabetes mellitus results from the autoimmune destruction of the insulin producing pancreatic β-cells. The autoimmune response begins months or even years before the presentation of hyperglycemic symptoms. Previous studies with other autoimmune diseases or acute inflammatory diseases testing the effect of the infusion of mesenchymal stem cells showed promising results in regulating immune system and promoting some degree of disease control. The aim of our study is to determine the safety and efficacy of intravenous infusions of mesenchymal stem cells in newly diagnosed type 1 diabetic patients.",
      "DetailedDescription": "Patients from 12 to 35 years old with type I diabetes mellitus proved by anti-pancreatic beta cell antibodies and recently diagnosed (less than 6 weeks) will be included in this study. First, bone marrow derived adult mesenchymal stem cells are collected from a first degree relative and cultured. After that, the patient receive 4 intravenous infusions 1 week apart followed by 4 infusion 4 months apart."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Diabetes Mellitus, Insulin-Dependent"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Diabetes mellitus",
          "Stem cells",
          "Autologous stem cell transplantation",
          "Autoimmune diseases"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Non-Randomized",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "10",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Intravenous mesenchymal stem cell",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "This group wil receive 8 intravenous infusions of mesenchymal stem cells. Four infusions 1 week apart and 4 infusions a month apart",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Intravenous Mesenchymal stem cell infusion"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Intravenous Mesenchymal stem cell infusion",
            "InterventionDescription": "Four consecutive intravenous infusions 1 week apart followed by 4 consecutive infusions 1 month apart",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Intravenous mesenchymal stem cell"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "AUC C-peptide levels during mixed meal tolerance test",
            "PrimaryOutcomeTimeFrame": "pré-treatment, 6 months, 12 months and then yearly (course of study 7 years)"
          },
          {
            "PrimaryOutcomeMeasure": "Safety",
            "PrimaryOutcomeDescription": "The process of analyzing safety data is made daily based on clinical interview, frequent physical examination and general laboratory findings weekly from the first stem cell infusion until 60 months after the last infusion. Chest X-ray will be performed in days 100, 180, 270, 360 after the lest infusion and then every 6 months. Fecal occult blood, alpha pheto protein, beta-human chorionic gonadotropin, carcino-embrionary antigen, abdomen ultrasound will be performed in month 6 and 12 after the last infusion and then yearly.",
            "PrimaryOutcomeTimeFrame": "Every 6 months until death"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Daily insulin use",
            "SecondaryOutcomeTimeFrame": "Daily (course of study is 7 years)"
          },
          {
            "SecondaryOutcomeMeasure": "Hemoglobin A1C",
            "SecondaryOutcomeTimeFrame": "3 months"
          },
          {
            "SecondaryOutcomeMeasure": "Anti-GAD titres",
            "SecondaryOutcomeTimeFrame": "Every 6 months"
          },
          {
            "SecondaryOutcomeMeasure": "Immunologic reconstitution parameters",
            "SecondaryOutcomeTimeFrame": "Yearly (course of study is 7 years)"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nType 1 diabetes mellitus diagnosed by clinical/metabolic parameters and positive anti-GAD antibodies\nLess than 6 weeks from diagnosis\n\nExclusion Criteria:\n\nPrevious diabetic ketoacidosis\nPregnancy\nSevere psychiatric disorder\nSevere organic impairment (renal, hepatic, cardiac, pulmonary)\nActive infectious disease\nPrevious or present neoplastic disease",
      "HealthyVolunteers": "Accepts Healthy Volunteers",
      "Gender": "All",
      "MinimumAge": "12 Years",
      "MaximumAge": "35 Years",
      "StdAgeList": {
        "StdAge": [
          "Child",
          "Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Julio Voltarelli, MD, PhD",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "+55 16 2101 9369",
            "CentralContactEMail": "jcvoltar@fmrp.usp.br"
          },
          {
            "CentralContactName": "Carlos E Couri",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "+5516 91495151",
            "CentralContactEMail": "ce.couri@yahoo.com.br"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Julio Voltarelli, MD, PhD",
            "OverallOfficialAffiliation": "University Hospital, School of Medicine of Ribeirão Preto, Brazil",
            "OverallOfficialRole": "Principal Investigator"
          },
          {
            "OverallOfficialName": "Carlos E Couri, MD, PhD",
            "OverallOfficialAffiliation": "University Hospital, School of Medicine of Ribeirão Preto, Brazil",
            "OverallOfficialRole": "Study Chair"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo",
            "LocationStatus": "Recruiting",
            "LocationCity": "Ribeirão Preto",
            "LocationState": "São Paulo",
            "LocationCountry": "Brazil",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Julio C Voltarelli, MD, PhD",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "+551621019369",
                  "LocationContactEMail": "jcvoltar@fmrp.usp.br"
                },
                {
                  "LocationContactName": "Carlos E Couri, MD, PhD",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "+551691495151",
                  "LocationContactEMail": "ce.couri@yahoo.com.br"
                },
                {
                  "LocationContactName": "Julio Voltarelli, MD, PhD",
                  "LocationContactRole": "Principal Investigator"
                },
                {
                  "LocationContactName": "Carlos E Couri, MD, PhD",
                  "LocationContactRole": "Sub-Investigator"
                }
              ]
            }
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000003920",
            "ConditionMeshTerm": "Diabetes Mellitus"
          },
          {
            "ConditionMeshId": "D000003922",
            "ConditionMeshTerm": "Diabetes Mellitus, Type 1"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000044882",
            "ConditionAncestorTerm": "Glucose Metabolism Disorders"
          },
          {
            "ConditionAncestorId": "D000008659",
            "ConditionAncestorTerm": "Metabolic Diseases"
          },
          {
            "ConditionAncestorId": "D000004700",
            "ConditionAncestorTerm": "Endocrine System Diseases"
          },
          {
            "ConditionAncestorId": "D000001327",
            "ConditionAncestorTerm": "Autoimmune Diseases"
          },
          {
            "ConditionAncestorId": "D000007154",
            "ConditionAncestorTerm": "Immune System Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M6267",
            "ConditionBrowseLeafName": "Diabetes Mellitus",
            "ConditionBrowseLeafAsFound": "Diabetes Mellitus",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M6269",
            "ConditionBrowseLeafName": "Diabetes Mellitus, Type 1",
            "ConditionBrowseLeafAsFound": "Diabetes Mellitus, Insulin-Dependent",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M3781",
            "ConditionBrowseLeafName": "Autoimmune Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M10791",
            "ConditionBrowseLeafName": "Metabolic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M24556",
            "ConditionBrowseLeafName": "Glucose Metabolism Disorders",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M7014",
            "ConditionBrowseLeafName": "Endocrine System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9352",
            "ConditionBrowseLeafName": "Immune System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC18",
            "ConditionBrowseBranchName": "Nutritional and Metabolic Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC19",
            "ConditionBrowseBranchName": "Gland and Hormone Related Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC20",
            "ConditionBrowseBranchName": "Immune System Diseases"
          }
        ]
      }
    }
  }
}